156 related articles for article (PubMed ID: 14658262)
1. [Efficacy and safety in the use of doxazosin (cardura) in the treatment of patients with benign prostatic hypertrophy (bph)].
Lopatkin NA; Aliaev IuG; Kogan MI; Loran OB; Mazo EB; Stepanov VN
Urologiia; 2003; (5):3-4. PubMed ID: 14658262
[No Abstract] [Full Text] [Related]
2. [Experience in the use of doxazosin in patients with benign hyperplasia of the prostate].
Lopatkin NA; Loran OB; Pushkar' DIu; Perepanova TS; Tevlin KP
Urol Nefrol (Mosk); 1998; (3):3-5. PubMed ID: 9644978
[TBL] [Abstract][Full Text] [Related]
3. Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.
Chung BH; Hong SJ; Lee MS
Int J Urol; 2005 Feb; 12(2):159-65. PubMed ID: 15733110
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy of a short-term regimen of Cardura XL on lower urinary tract symptoms and international prognostic scoring system in the treatment of benign prostatic hyperplasia].
Zhang P; Wu ZJ; Yang Y; Zhang XD
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2826-9. PubMed ID: 21162792
[TBL] [Abstract][Full Text] [Related]
5. Controlled-release doxazosin in the treatment of benign prostatic hyperplasia.
Hernandez C; Duran R; Jara J; Castaño I; Moralejo M
Prostate Cancer Prostatic Dis; 2005; 8(4):375-80. PubMed ID: 16264771
[TBL] [Abstract][Full Text] [Related]
6. Doxazosin-alpha-1-adrenergic antagonists drug in the long-term (3 years). Management of benign prostatic hyperplasia.
Dutkiewicz S
Mater Med Pol; 1996; 28(3):93-102. PubMed ID: 9167419
[TBL] [Abstract][Full Text] [Related]
7. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
Gratzke P; Kirby RS
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
Chung BH; Hong SJ
BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335
[TBL] [Abstract][Full Text] [Related]
9. The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.
Fitzpatrick JM; Desgrandchamps F
BJU Int; 2005 Mar; 95(4):575-9. PubMed ID: 15705083
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of doxazosin in normotensive and hypertensive patients with benign prostatic hyperplasia.
Kirby RS
Scand J Urol Nephrol Suppl; 1995; 168():29-33. PubMed ID: 7541549
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I
Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
[TBL] [Abstract][Full Text] [Related]
12. [Tonocardin (doxazosin) in treating lower urinary tract symptoms].
Mazo EB; Chepurov DA
Urologiia; 2003; (3):15-6. PubMed ID: 12846089
[TBL] [Abstract][Full Text] [Related]
13. The effect of doxazosin on sexual function in patients with benign prostatic hyperplasia, hypertension, or both.
Flack JM
Int J Clin Pract; 2002 Sep; 56(7):527-30. PubMed ID: 12296615
[TBL] [Abstract][Full Text] [Related]
14. [Single-blind study of the effect of doxazosin mesylate in benign prostatic hypertrophy].
Siracusano S; Paoni A; Tomasi PA; Deriu M; Trombetta C; Belgrano E
Prog Urol; 1994 Dec; 4(6):1017-21. PubMed ID: 7533030
[TBL] [Abstract][Full Text] [Related]
15. Doxazosin gastrointestinal therapeutic system versus tamsulosin for the treatment of benign prostatic hyperplasia: a study in Chinese patients.
Xue Z; Zhang Y; Ding Q; He Z; Wang J; Xu K
Int J Urol; 2007 Feb; 14(2):118-22. PubMed ID: 17302567
[TBL] [Abstract][Full Text] [Related]
16. [Cardura (doxazosin) in the treatment of prostatic adenoma].
Boĭko NI
Lik Sprava; 1997; (5):135-7. PubMed ID: 9491722
[TBL] [Abstract][Full Text] [Related]
17. [Doxazosin in the treatment of benign prostatic hypertrophy].
Rollema HJ; Janknegt RA
J Urol (Paris); 1993; 99(6):314-5. PubMed ID: 7516377
[No Abstract] [Full Text] [Related]
18. Drug combo stalls BPH progression.
Health News; 2004 Feb; 10(2):9. PubMed ID: 15032153
[No Abstract] [Full Text] [Related]
19. [Use of doxazosin (Cardura-Pfizer), alpha 1-adrenoreceptor antagonist, in treatment of hypertension in patients with diabetes].
Grzeszczak W
Wiad Lek; 1998; 51 Suppl 2():5-10. PubMed ID: 9686527
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction.
Kirby RS; O'Leary MP; Carson C
BJU Int; 2005 Jan; 95(1):103-9; discussion 109. PubMed ID: 15638905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]